
    
      The trial will be performed in two "phases" (Periods):

      Period 1: Initial phase in which the recommended phase 2 dose (RP2D) is determined

      Period 2: Extension phase in which participants who are deriving benefit (stable disease or
      better) will have the opportunity to continue treatment at the discretion of the Investigator
    
  